Skip to main content
Top
Published in: Clinical Rheumatology 9/2008

01-09-2008 | Brief Report

Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly

Authors: Angela G. Juby, Paul Davis

Published in: Clinical Rheumatology | Issue 9/2008

Login to get access

Abstract

Canadian Consensus guidelines regarding appropriate use of nonsteroidal anti-inflammatory drugs (NSAID) were recently published. This study was done to evaluate the application of these guidelines on NSAID practice patterns in frail elderly patients referred to a specialist Geriatric Assessment Clinic. A retrospective chart review was undertaken of referrals who were currently prescribed NSAIDs. Data were captured on age, sex, weight, diagnoses, medications and dosages, indication for NSAID treatment, lying BP (as assessed in the clinic) and recent serum creatinine result. Creatinine clearance was subsequently calculated use the Cockcroft–Gault equation. Complete data were available on 107 patients (68% women, average age 80.6 years). Thirty percent were on a traditional NSAID, the remainder were on a Coxib. Concomitant aspirin was prescribed in 37%. Cytoprotection was being used in 38% and did not increase appreciably in patients with additional risk factors for GI toxicity, i.e., concomitant aspirin usage(35%), and history of GI toxicity (48%). Sixty-seven were taking anti-hypertensive medications, although more than two thirds of these patients were uncontrolled. Newly diagnosed hypertension was present in 19.6%. Calculated creatinine clearance revealed moderate to severe renal impairment in 79% of subjects, although serum creatinine was only elevated in 18%. In total, 70% of subjects were found to have relative or absolute risk factors for NSAID therapy. Given the high prevalence of potential contraindications to anti-inflammatory drug usage in this study, we advocate the dissemination and application of these guidelines in geriatric patients in an attempt to reduce potential morbidity and mortality.
Literature
1.
go back to reference Tannenbaum H, Bombardier C, Davis P, Russell AS (2006) Third Canadian Consensus Conference Group. An evidence-based approach to prescribing nonsteroidal anti-inflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 33(1):140–157PubMed Tannenbaum H, Bombardier C, Davis P, Russell AS (2006) Third Canadian Consensus Conference Group. An evidence-based approach to prescribing nonsteroidal anti-inflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 33(1):140–157PubMed
2.
go back to reference Tannenbaum H, Davis P, Russell AS et al (1996) An evidence based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus participants. CMAJ 155:77–88PubMed Tannenbaum H, Davis P, Russell AS et al (1996) An evidence based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus participants. CMAJ 155:77–88PubMed
3.
go back to reference Tannenbaum H, Peloso PMJ, Russell AS, Marlow B (2000) An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 7(Suppl A):4A–16APubMed Tannenbaum H, Peloso PMJ, Russell AS, Marlow B (2000) An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 7(Suppl A):4A–16APubMed
4.
go back to reference Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and Rheumatoid Arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247–1255PubMedCrossRef Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and Rheumatoid Arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247–1255PubMedCrossRef
5.
go back to reference Whelton A, Schulman G, Wallemark C et al (2000) Effect of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 169:1465–1470CrossRef Whelton A, Schulman G, Wallemark C et al (2000) Effect of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 169:1465–1470CrossRef
6.
go back to reference Sonomon DH, Schneeweiss S, Levin R, Avorn J (2004) Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44:140–145CrossRef Sonomon DH, Schneeweiss S, Levin R, Avorn J (2004) Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44:140–145CrossRef
7.
go back to reference Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR (2002) Non-steroidal and anti-inflammatory drugs and risk of serious coronary heart disease: an observational study. Lancet 359:118–123PubMedCrossRef Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR (2002) Non-steroidal and anti-inflammatory drugs and risk of serious coronary heart disease: an observational study. Lancet 359:118–123PubMedCrossRef
8.
go back to reference Visser LE, Graatsma HH, Tricker BHC (2002) Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 53:183–188PubMedCrossRef Visser LE, Graatsma HH, Tricker BHC (2002) Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 53:183–188PubMedCrossRef
9.
go back to reference Abraham NS, El-Serag HB, Johnson ML (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. J Gastroenterol 129:1171–1178CrossRef Abraham NS, El-Serag HB, Johnson ML (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. J Gastroenterol 129:1171–1178CrossRef
10.
go back to reference Van Leen MWF, Van Der Eijk I, Schols JMGA (2007) Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. Age Ageing 36:414–418PubMedCrossRef Van Leen MWF, Van Der Eijk I, Schols JMGA (2007) Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. Age Ageing 36:414–418PubMedCrossRef
11.
go back to reference Catella-Lawson F, Reilly MP, Kapoor SC et al (200) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817CrossRef Catella-Lawson F, Reilly MP, Kapoor SC et al (200) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817CrossRef
12.
go back to reference Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359:14–22PubMedCrossRef Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359:14–22PubMedCrossRef
13.
go back to reference Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31–40PubMedCrossRef Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31–40PubMedCrossRef
14.
go back to reference Davis P, Juby A (2007) Osteoarthritis. Therapeutic choices, 5th edn., Chapter 71. Canadian Pharmacists Association, Canada, pp 939–952 Davis P, Juby A (2007) Osteoarthritis. Therapeutic choices, 5th edn., Chapter 71. Canadian Pharmacists Association, Canada, pp 939–952
Metadata
Title
Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly
Authors
Angela G. Juby
Paul Davis
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0952-7

Other articles of this Issue 9/2008

Clinical Rheumatology 9/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.